TFF Pharmaceuticals Inc
NASDAQ:TFFP

Watchlist Manager
TFF Pharmaceuticals Inc Logo
TFF Pharmaceuticals Inc
NASDAQ:TFFP
Watchlist
Price: 0.065 USD Market Closed
Market Cap: 288.6k USD

Operating Margin

-1 610.8%
Current
Improving
by 1 800.4%
vs 3-y average of -3 411.2%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-1 610.8%
=
Operating Income
$-18.7m
/
Revenue
$1.2m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-1 610.8%
=
Operating Income
$-18.7m
/
Revenue
$1.2m

Peer Comparison

Country Company Market Cap Operating
Margin
US
TFF Pharmaceuticals Inc
NASDAQ:TFFP
288.6k USD
Loading...
US
Eli Lilly and Co
NYSE:LLY
982.2B USD
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
US
Johnson & Johnson
NYSE:JNJ
526.1B USD
Loading...
CH
Roche Holding AG
SIX:ROG
276.2B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
215.4B GBP
Loading...
CH
Novartis AG
SIX:NOVN
221.7B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
270.7B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
145.8B USD
Loading...
No Stocks Found

Market Distribution

Lower than 95% of companies in the United States of America
Percentile
5th
Based on 14 112 companies
5th percentile
-1 610.8%
Low
-4 087 900% — -5.1%
Typical Range
-5.1% — 14.8%
High
14.8% — 1 032 600%
Distribution Statistics
the United States of America
Min -4 087 900%
30th Percentile -5.1%
Median 6%
70th Percentile 14.8%
Max 1 032 600%

TFF Pharmaceuticals Inc
Glance View

Market Cap
288.6k USD
Industry
Pharmaceuticals

TFF Pharmaceuticals, Inc. engages in the development and commercialization of drug products based on its patented Thin Film Freezing technology platform. The company is headquartered in Austin, Texas. The company went IPO on 2019-10-25. The firm is focused on developing and commercializing drug products based on its Thin Film Freezing (TFF) technology platform. Its TFF platform is designed to enable solubility of poorly water-soluble drugs. Its drug candidates include TFF Voriconazole Inhalation Powder (VIP), TFF Tacrolimus Inhalation Powder (TIP) and Triple Combination. The company is developing TFF VIP to treat invasive pulmonary aspergillosis (IPA), a severe fungal pulmonary disease. TFF VIP is being developed as an inhaled dry powder drug. The company is developing TFF TIP, a dry powder version of Tacrolimus, an immunosuppressive drug used in transplant medicine. The company is developing Triple Combination, a dry powder drug combination to treat chronic obstructive pulmonary disease (COPD) and asthma. Its other dry powder products include Inhaled SARS-CoV2 Monoclonal Antibody, Niclosamide Inhalation Powder, Cannabidiol (CBD) and Vaccines.

TFFP Intrinsic Value
Not Available
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-1 610.8%
=
Operating Income
$-18.7m
/
Revenue
$1.2m
What is TFF Pharmaceuticals Inc's current Operating Margin?

The current Operating Margin for TFF Pharmaceuticals Inc is -1 610.8%, which is above its 3-year median of -3 411.2%.

How has Operating Margin changed over time?

Over the last 3 years, TFF Pharmaceuticals Inc’s Operating Margin has increased from -39 442.9% to -1 610.8%. During this period, it reached a low of -39 442.9% on Aug 30, 2021 and a high of -1 610.8% on Oct 30, 2024.

Back to Top